How Patients Lose Their Own Voices: Disparities in Patient-Reported Outcome Capture in Clinical Trials
It remains important to interrogate how structural discrimination influences the collection of patient-reported outcomes.
Brain Cancer
BRAIN CANCER ADVISOR
FEATURED CONTENT
-
-
Children With Cancer Not Experiencing as Severe COVID-19 as Initially Feared
Studies suggest that the majority of pediatric patients with cancer and COVID-19 experience mild disease — rather than severe disease — as a result of infection with the novel virus. -
Upfront Radiation May Be a Cost-Effective Strategy in Oligorecurrent Hormone-Sensitive Prostate Cancer
Upfront metastasis-directed therapy may be a viable treatment approach in patients with oligorecurrent disease, particularly those who wish to defer systemic therapy. -
New Class of Drug Appears to Extend Survival in Patients With Triple-Refractory Multiple Myeloma
Oncopeptides will seek accelerated approval from the FDA after melflufen demonstrates a manageable safety profile. -
Study Points to a Rise in Renal Carcinomas in Children
The increase is thought to be related to environmental factors.
BRAIN CANCER NEWS
FDA Grants Orphan Drug Status to Berubicin for Malignant Gliomas
CheckMate 143: Nivolumab Produces Disappointing Results in Patients with Recurrent Glioblastoma
Short Treatment Delays May Not Hamper Survival in Glioblastoma
Fewer Children Enrolling in Pediatric Cancer Trials
Pediatric Brain Cancer Outcomes Worse for Black, Hispanic Patients
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Brain Cancer
